SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers:
SEC Accession No. 0001193125-18-102103
Filing Date
2018-03-29
Accepted
2018-03-29 16:52:36
Documents
9
Effectiveness Date
2018-03-29

Document Format Files

Seq Description Document Type Size
1 S-3ASR d556584ds3asr.htm S-3ASR 356196
2 EX-1.2 d556584dex12.htm EX-1.2 163573
3 EX-4.4 d556584dex44.htm EX-4.4 32919
4 EX-4.5 d556584dex45.htm EX-4.5 261052
5 EX-5.1 d556584dex51.htm EX-5.1 33727
6 EX-12.1 d556584dex121.htm EX-12.1 7288
7 EX-23.1 d556584dex231.htm EX-23.1 1372
8 GRAPHIC g556584g0322072833806.jpg GRAPHIC 6601
9 GRAPHIC g556584g08i95.jpg GRAPHIC 54682
  Complete submission text file 0001193125-18-102103.txt   941888
Mailing Address 600 CALIFORNIA ST., 17TH FLOOR SAN FRANCISCO CA 94108
Business Address 600 CALIFORNIA ST., 17TH FLOOR SAN FRANCISCO CA 94108 415-638-6556
Audentes Therapeutics, Inc. (Filer) CIK: 0001628738 (see all company filings)

IRS No.: 461606174 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3ASR | Act: 33 | File No.: 333-224020 | Film No.: 18723608
SIC: 2836 Biological Products, (No Diagnostic Substances)